When DU145 clone 4, which shows limited knockdown of WASF3, was compared with clones 8 and 14, which show extensive knockdown, a clear reduction in wound-healing capability was noted in the knockdown cells (Figure 3), further supporting the relationship between WASF3 expression and cell motility in prostate cancer cells. Here, WASF3 is linked to prostate cancer.